Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly

RecruitingOBSERVATIONAL
Enrollment

136

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Metformin

Patients will begin treatment with metformin administered orally at a starting dose of 425 mg / day every 12 hours for the first 15 days and then continue with a dose of 850 mg / day until the end of the study. The beginning of this treatment phase will be following the recommendations of the clinical guidelines (Comprehensive Approach to Type 2 Diabetes Mellitus, SEEN V2019.2)

Trial Locations (1)

17007

RECRUITING

Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona

All Listed Sponsors
lead

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

OTHER